S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.35%) $0.927
USD/NOK
(0.79%) $10.85
USD/GBP
(0.11%) $0.792
USD/RUB
(0.16%) $92.59

Realtime updates for Solid Biosciences Inc [SLDB]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-03-28)

Expected move: +/- 13.55%

BUY
100.00%
return 9.76%
SELL
66.67%
return -0.65%
Last Updated28 Mar 2024 @ 16:00

-6.53% $ 13.32

SELL 62407 min ago

@ $8.00

Issued: 14 Feb 2024 @ 09:30


Return: 66.50%


Previous signal: Feb 13 - 09:30


Previous signal: Buy


Return: 4.30 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy...

Stats
Today's Volume 817 874
Average Volume 354 736
Market Cap 502.92M
EPS $-1.050 ( 2023-11-08 )
Next earnings date ( $-0.570 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.76
ATR14 $0.0530 (0.40%)
Insider Trading
Date Person Action Amount type
2024-02-13 Hanrahan Jessie Buy 65 000 Employee Stock Option (Right to Buy)
2024-02-13 Hanrahan Jessie Buy 32 500 Restricted Stock Units
2024-02-13 Cumbo Alexander Buy 240 250 Employee Stock Option (Right to Buy)
2024-02-13 Cumbo Alexander Buy 120 125 Restricted Stock Units
2024-02-13 Brooks Gabriel Buy 87 500 Employee Stock Option (Right to Buy)
INSIDER POWER
95.53
Last 96 transactions
Buy: 8 087 237 | Sell: 205 981

Volume Correlation

Long: 0.07 (neutral)
Short: -0.91 (very strong negative)
Signal:(55.397) Neutral

Solid Biosciences Inc Correlation

10 Most Positive Correlations
CIZN0.814
10 Most Negative Correlations
CATB-0.823

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Solid Biosciences Inc Correlation - Currency/Commodity

The country flag -0.12
( neutral )
The country flag -0.06
( neutral )
The country flag 0.00
( neutral )
The country flag 0.25
( neutral )
The country flag -0.30
( neutral )
The country flag 0.06
( neutral )

Solid Biosciences Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-2.58M (0.00 %)
EPS: $-4.83
Q4 2023
Revenue: $0
Gross Profit: $-587 000 (0.00 %)
EPS: $-1.000
Q3 2023
Revenue: $0
Gross Profit: $-588 000 (0.00 %)
EPS: $-1.050
Q2 2023
Revenue: $0
Gross Profit: $-703 000 (0.00 %)
EPS: $-1.250

Financial Reports:

No articles found.

Solid Biosciences Inc

Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candidate for the treatment of duchenne muscular dystrophy. It also engages in developing of platform technologies, including dual gene expression, a technology for packaging multiple transgenes into one vector, as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators